New Delhi, Nov. 11 -- The US Food and Drug Administration (FDA) has asked makers of all GLP-1 receptor agonist medicines to add a warning to their labels about a possible link to a rare but serious ey... Read More
New Delhi, Nov. 10 -- With Delhi reeling under severe air pollution, doctors have advised people, who have the option, to leave the city for a few days until air quality improves. Dr Rajesh Chawla, s... Read More
New Delhi, Nov. 5 -- Months after a joint inspection recommended an immediate halt to all manufacturing at a pharmaceutical plant in Uttarakhand, there is no record that anyone acted on it and the com... Read More
New Delhi, Nov. 2 -- For more than four decades, India's drug price regulator has been trying to recover money from pharmaceutical companies that charged patients more than the prices allowed under th... Read More
New Delhi, Nov. 2 -- Meeta Singh, 42, who works at a salon in Delhi, was alarmed when a large private hospital quoted around Rs.1 lakh for a laparoscopic surgery for gallbladder removal, without a bre... Read More
New Delhi, Oct. 29 -- Before the government capped trade margins, a patient buying some anti-cancer drugs in India could have been paying ten or even fifteen times from what the same medicine they wil... Read More
New Delhi, Oct. 29 -- Prices of almost all single-source cancer drug entries on the government's revised price list remain unchanged despite the Centre's decision to cap trade margins at 30 per cent, ... Read More
New Delhi, Oct. 28 -- A revised drug price list published by the National Pharmaceutical Pricing Authority (NPPA) shows how the government's 30 per cent cap on trade margins for cancer drugs is playin... Read More
New Delhi, Oct. 28 -- Amid concerns over the high cost of healthcare in India, hospital and industry leaders have questioned whether government-determined treatment rates adequately reflect the cost o... Read More
New Delhi, Oct. 28 -- The Indian Patent Office has rejected a patent application by the US-based Global Alliance for TB Drug Development (TB Alliance) for BPaL, a treatment for drug-resistant tubercul... Read More